Stock OSAPQ PROSOMNUS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases ProSomnus, Inc.

Equities

OSAPQ

US50535E1082

Market Closed - OTC Markets
Other stock markets
 12:09:40 2024-06-20 EDT 		5-day change 1st Jan Change
0.0119 USD -0.83% Intraday chart for ProSomnus, Inc. -52.40% -98.79%
05-24 Joint Reorganization Plan and Disclosure Statement Filed by ProSomnus, Inc. CI
05-20 ProSomnus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
GL
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
GL
ProSomnus : Announces Strong First Quarter 2024 Revenue Growth - Form 8-K
PU
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
GL
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
GL
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
GL
ProSomnus : Material Agreement - Form 8-K
PU
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
GL
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
AQ
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
GL
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
GL
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
GL
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
AQ
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
GL
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
AQ
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
GL
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
AQ
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
GL
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
AQ
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OSAPQ Stock
  4. News ProSomnus, Inc.
  5. Press Releases